← Leaderboards
William M Marsiglia
New York University
$2,474,539
Attributed
$2,474,539
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,474,539 · 3
By mechanism
R35$2,011,691 · 1
K00$373,728 · 1
F99$89,120 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University
Same institution · by research overlap
- Shohei Koide$16,409,478
- Da-Neng Wang$18,349,403
- Nathaniel J. Traaseth$7,360,173
- Yi Ye$8,884,555
- John S Evans$533,532
Others in their field
Top investigators on “Binding”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Barton F Haynes · Duke University$280,359,422
- David Heimbrook · Leidos Biomedical Research, Inc.$116,636,515
- Michael P Snyder · Yale University$97,195,243
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
Research focus
BindingSignal TransductionBiologyInsightCellsMolecular ConformationMolecularDrug DesignAffectDrug DevelopmentAttenuatedAmino AcidsCancer EtiologyBaseDrug Binding SiteDoctor Of PhilosophyDrug ResistanceChargeBiological ModelsAspartic AcidBinding SitesDisease-Causing MutationDesignAntineoplastic Agents
Grant awards (7)
Probing the Effects of Pathological Conditions on AKT$2,011,691
R35 · FY2025 · GM · contact PI
Defining the relationship between kinase inhibitor pharmacophores and pro-/anti-targets using in vivo models of colorectal cancer$99,870
K00 · FY2022 · CA · contact PI
Defining the relationship between kinase inhibitor pharmacophores and pro-/anti-targets using in vivo models of colorectal cancer$95,308
K00 · FY2021 · CA · contact PI
Defining the relationship between kinase inhibitor pharmacophores and pro-/anti-targets using in vivo models of colorectal cancer$90,746
K00 · FY2020 · CA · contact PI
Defining the relationship between kinase inhibitor pharmacophores and pro-/anti-targets using in vivo models of colorectal cancer$87,804
K00 · FY2019 · CA · contact PI
Mechanisms of resistance and activation conferred by kinases displaying hinge and gate-keeper mutations$44,044
F99 · FY2017 · CA · contact PI
Mechanisms of resistance and activation conferred by kinases displaying hinge and gate-keeper mutations$45,076
F99 · FY2016 · CA · contact PI